Fixed drug eruption in the practice of the allergist-immunologist

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Fixed drug eruption is a type of allergic reaction to a medicine. The mechanism of this disease is delayed type of hypersensitivity. The spectrum of causative medicines can be variable. A careful history and drug provocation tests in vivo in most cases allow to make a diagnosis accurately and identify the offending drug allergen.

Full Text

Restricted Access

About the authors

T S Romanova

Institute of Immunology

Email: ts romanova@mail.ru
Moscow, Russia

T N Myasnikova

Institute of Immunology

Moscow, Russia

L G Khludova

Institute of Immunology

Moscow, Russia

T V Latysheva

Institute of Immunology

Moscow, Russia

References

  1. Hunziker T., Kunzi U.P., Braunschweig S. et al. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy. 1997, v. 52, p. 388-393
  2. Turk B.G., Gunaydin A., Ertam I., Ozturk G. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance. Cutan. Ocul. Toxicol. 2013, v. 32 (1), p. 41-45.
  3. Ozkaya-Bayazit E., Akar U. Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype. J. Am. Acad. Dermatol. 2001, v. 45, p. 712-717.
  4. Brahimi N., Routier E., Raison-Peyron N. et al. A three-year-analysis of fixed drug eruptions in hospital settings in France. Eur. J. Dermatol. 2010, v. 20, p. 461-464.
  5. Andrade P., Brinca A., Gonçalo M. Patch testing in fixed drug eruptions - a 20-year review. Contact Dermatitis. 2011, v. 65, p. 195-201.
  6. Ring J., Blaser K., Capron M. et al. Adverse cutaneous drug eruption. Chem. Immunol. Allergy. 2012, v. 97, p. 240.
  7. Korkij W., Soltani K. Fixed drug eruption. Arch. Dermatol. 1984, v. 120, p. 520-524.
  8. Mizukawa Y., Shiohara T. Trauma-localized fixed drug eruption: involvement of burn scars, insect bites and venipuncture sites. Dermatology. 2002, v. 205, p. 159-161.
  9. Sigal-Nahum M., Konqui A., Gaulier A. et al. Linear fixed drug eruption. Br. J. Dermatol. 1988, v. 118, p. 849-851.
  10. Senturk N., Yanik F., Yildiz L. et al. Topotecan - induced cellulitis like fixed drug eruption. J. Eur. Acad. Dermatol. Venereol. 2002, v. 16, p. 414-416.
  11. Guin J.D., Baker G.F. Chronic fixed drug eruption caused by acetaminophen. Cutis. 1988, v. 4, p. 106-108.
  12. Rijlaarsdam U., Scheffer E., Meijer C.J. et al. Mycosis fungoi-des - like lesions associated with phenytoin and carbamazepine therapy. J. Am. Acad. Dermatol. 1991, v. 24, p. 216-220.
  13. Shiohara T., Mizukawa Y. The immunological basis of lichenoid tissue reaction. Autoimmune Rev. 2005, v. 4, p. 236-241.
  14. Shelley W.B., Shelley E.D. Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline. J. Am. Acad. Dermatol. 1987, v. 17, p. 403-407.
  15. Desmeules H. Nonpigmenting fixed drug eruption after anesthesia. Anesth. Analg. 1990, v. 70, p. 216-217.
  16. Barbaud A., Goncalo M., Bruynzeel D. et al. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001, v. 45, p. 321-328.

Statistics

Views

Abstract: 134

PDF (Russian): 1

Article Metrics

Metrics Loading ...

Dimensions

PlumX


Copyright © Pharmarus Print Media, 2017



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies